We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Iris Nova Stock

Invest in or calculate the value of your shares in Iris Nova or other pre-IPO companies through EquityZen's platform.

Get Started

Iris Nova Stock (IRNO)

Iris Nova is a beverage company which sells directly to consumers

About Iris Nova Stock

Founded

2015

Headquarters

New York, NY, US

Total Funding

15.1M

Industries

Software, Artificial Intelligence, Data and Analytics

We believe the future of the beverage industry will be built through direct communication with customers. Our proprietary, first-to-market tech platform offers a frictionless ordering and customer service experience, featuring beverages tailored to meet the needs of the modern consumer. Conversational Commerce (cCommerce) blends natural conversation and consumption data, giving us a powerful ability to formulate and deliver innovative beverage products without the shelf-space constraints that currently plague the traditional beverage industry. We introduced this innovative sales model in 2015 with the launch of our first brand, DIRTY LEMON. Since that time, our portfolio has expanded to include an experiential retail property, The Drug Store. Two additional beverage brand concepts will be launched in 2019. Iris Nova , Latin for “new lens,” is a nod to looking at the industry with a refreshed perspective and a renewed sense of opportunity.

Iris Nova Management

Leadership team at Iris Nova

Founder & CEO

Zak Normandin

Chief Technology Officer

Greg Leuch

Locked Features

Join now and verify your accreditation status to gain access to:

  • Iris Nova current valuation
  • Iris Nova stock price
  • Available deals in Iris Nova and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Iris Nova stock?

Accredited investors can buy pre-IPO stock in companies like Iris Nova through EquityZen funds. These investments are made available by existing Iris Nova shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Iris Nova stock?

Shareholders can sell their Iris Nova stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."